Radiomics on Dual-energy (spectral) CT for Early Recurrence Prediction of Hepatocellular Carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040861

Enrollment

Unknown

Registered

2020-12-12

Start date

2021-12-01

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:Histopathology

Index test:radiomics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.A pathological specimen was obtained by resection and was diagnosed as HCC; 2.Without radiotherapy and chemotherapy before scanning; 3.Scanning CT within 1 week before operation.

Exclusion criteria

Exclusion criteria: 1.No indication of surgical treatment, no tumor specimen; 2.Serious allergic history of iodine contrast agent; 3.poor image quality.

Design outcomes

Primary

Measure	Time frame
Radiomics;SEN, SPE, ACC, AUC of ROC, PV+, PV-;	—

Countries

China

Contacts

Public ContactBin Song

Department of Radiology, West China Hospital of Sichuan University

cjr.songbin@vip.163.com+86 18980601592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026